Zobrazeno 1 - 10
of 381
pro vyhledávání: '"ChaoLin Huang"'
Autor:
Ying Liu, Jiayou Zhang, Wen Liu, Yongbing Pan, Shunan Ruan, Xuanxuan Nian, Wei Chen, Lina Sun, Qiangling Yin, Xin Yue, Qingliang Li, Fang Gui, Cong Wu, Shuzhen Wang, Yunkai Yang, Zhaofei Jing, Feiguang Long, Zejun Wang, Zeyu Zhang, Chaolin Huang, Kai Duan, Mifang Liang, Xiaoming Yang
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTFollowing the national dynamic zero-COVID strategy adjustment, the utilization of broad-spectrum nasal neutralizing antibodies may offer an alternative approach to controlling the outbreak of Omicron variants between late 2022 and early 2023
Externí odkaz:
https://doaj.org/article/0b3823c6fe634e4ca1410f864e19a3f0
Autor:
Lingqian Tian, Yongli Zhang, Qiuhong Liu, Lianguo Ruan, Fuli Ren, Yang Han, Yanfang Zhang, Lei Yang, Sha Li, Hao Sun, Yecheng Zhang, Yuan Zhou, Rongjuan Pei, Fei Deng, Chaolin Huang, Xinwen Chen, Yun Wang
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/8d9118badee745a498bb66e94a19da6b
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectivePolycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder that impacts 8-13% of women in their reproductive years. However, the drugs commonly used to treat PCOS are often prescribed off-label and may carry potential s
Externí odkaz:
https://doaj.org/article/bc7c042e3b8f499186fe832c1c664862
Publikováno v:
The Innovation, Vol 5, Iss 6, Pp 100720- (2024)
Externí odkaz:
https://doaj.org/article/8a6dc325285348abb0a72d456a26699c
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveHec1 is a component of the Ndc80 kinetochore complex and is frequently upregulated in various cancers. However, the clinical significance of Hec1 in cervical cancer remains largely unknown. This study aimed to investigate the expression patt
Externí odkaz:
https://doaj.org/article/11f5173f4d8b4f03b5d7b0eef0bc21e7
Autor:
Jun Ye, Jianchao Ying, Haixia Chen, Zhiping Wu, Chaolin Huang, Chuan Zhang, Zhitao Chen, Haini Chen
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Our previous studies have indicated that mRNA and protein levels of PPIH are significantly upregulated in Hepatocellular Carcinoma (LIHC) and could act as predictive biomarkers for patients with LIHC. Nonetheless, the expression a
Externí odkaz:
https://doaj.org/article/ae77ad5543154c6fb460b7b92c1d9532
Autor:
Chaolin Huang, Xujuan Hu, Delong Wang, Rui Gong, Qiongya Wang, Fuli Ren, Yuanjun Wu, Juan Chen, Xianglian Xiong, Huadong Li, Qian Wang, Gangyu Long, Dingyu Zhang, Yang Han
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Various substances in the blood plasma serve as prognostic indicators of the progression of COVID-19. Consequently, multi-omics studies, such as proteomic and metabolomics, are ongoing to identify accurate biomarkers. Cytokines and chemokine
Externí odkaz:
https://doaj.org/article/67d666b1c28543e4a393c6f683e00822
Autor:
Hao Meng, Zhiying Liao, Yanting Ji, Dong Wang, Yang Han, Chaolin Huang, Xujuan Hu, Jingyi Chen, Hengrui Zhang, Zonghong Li, Changliang Wang, Hui Sun, Jiaqi Sun, Lihua Chen, Jiaxiang Yin, Jincun Zhao, Tao Xu, Huisheng Liu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-15 (2024)
Abstract The angiotensin-converting enzyme 2 (ACE2) is a primary cell surface viral binding receptor for SARS-CoV-2, so finding new regulatory molecules to modulate ACE2 expression levels is a promising strategy against COVID-19. In the current study
Externí odkaz:
https://doaj.org/article/e844022f63894ad3bd43c2f333cac2d5
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/4caf49914c47458dafb7a20374120250
Autor:
Yangqing Zhan, Zhengshi Lin, Jingyi Liang, Ruilin Sun, Yueping Li, Bingliang Lin, Fangqi Ge, Ling Lin, Hongzhou Lu, Liang Su, Tianxin Xiang, Hongqiu Pan, Chaolin Huang, Ying Deng, Furong Wang, Ruhong Xu, Dexiong Chen, Ping Zhang, Jianlin Tong, Xifu Wang, Qingwei Meng, Zhigang Zheng, Shuqiang Ou, Xiaoyun Guo, Herui Yao, Tao Yu, Weiyang Li, Yu Zhang, Mei Jiang, Zhonghao Fang, Yudi Song, Ruifeng Chen, Jincan Luo, Changyuan Kang, Shiwei Liang, Haijun Li, Jingping Zheng, Nanshan Zhong, Zifeng Yang, Huang Yanming, M.M, Dong Haiping, M.D., Jinlin Hou, M.M, Shao Lei, M.D., Li Xiaoguang, M.D., Gao Yan, M.M.
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102359- (2024)
Summary: Background: Leritrelvir is a novel α-ketoamide based peptidomimetic inhibitor of SARS-CoV-2 main protease. A preclinical study has demonstrated leritrelvir poses similar antiviral activities towards different SARS-CoV-2 variants compared wi
Externí odkaz:
https://doaj.org/article/47dbfffb279a4d67b276d3a4042f438c